Skin cream horror storyNew Zealand HeraldHe prescribed six prednisone tablets and a hydrocortisone cream – and asked for the name of the products that had so disfigured me. A Google search revealed that this particular skincare range had affected other…
New Stem Cell Transplant Center Opens in Philadelphia – PR Newswire (press release)
|
New Stem Cell Transplant Center Opens in Philadelphia
PR Newswire (press release) Pamela Crilley, DO, chief of medical oncology at Cancer Treatment Centers of America in Philadelphia, offers information about the hospital’s new nearly-17,000 square foot Stem Cell Transplant and Cell Therapy Unit. Dr. Crilley and a team of . Cancer hospital adds stem cell unitPhiladelphia Business Journal |
Stock Analysts' Ratings Reiterations for July, 1st (AMP, BBRY, BIIB, COH, CRM … – Zolmax
|
Stock Analysts’ Ratings Reiterations for July, 1st (AMP, BBRY, BIIB, COH, CRM …
Zolmax … in particular unpublished estimates) now fully reflect Tecfidera’s strong launch, in our view, and upside in BIIB shares will likely require pipeline success, which is not expected until 2014 data readouts from anti-LINGO Phase II (optic neuritis … |
Hindustan Times – Hindustan Times
Hindustan TimesHindustan TimesWith reference to the report Donate: gift a life (June 30), it is appalling that even as India is making rapid strides in the development of science and technology, people in our country are reluctant to pledge their organ…
Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market … – Sacramento Bee
Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market …Sacramento BeeThe currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market, constituting four of the …
Biogen Idec Stock Rating Reaffirmed by Piper Jaffray (BIIB) – Zolmax
|
Biogen Idec Stock Rating Reaffirmed by Piper Jaffray (BIIB)
Zolmax … in particular unpublished estimates) now fully reflect Tecfidera’s strong launch, in our view, and upside in BIIB shares will likely require pipeline success, which is not expected until 2014 data readouts from anti-LINGO Phase II (optic neuritis … |
DUBLIN, July 1, 2013 /PRNewswire/ — – PR Newswire (press release)
DUBLIN, July 1, 2013 /PRNewswire/ –PR Newswire (press release)The currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market, constituting four of the global top 20 best-selli…
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies – PR Newswire UK (press release)
Competitor Analysis: Biosimilar and Biosuperior Therapeutic AntibodiesPR Newswire UK (press release)This report provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next gen…
UPDATE: Piper Jaffray Raises PT on Biogen Idec on Multiple Positive Factors – Benzinga
|
UPDATE: Piper Jaffray Raises PT on Biogen Idec on Multiple Positive Factors
Benzinga … in particular unpublished estimates) now fully reflect Tecfidera’s strong launch, in our view, and upside in BIIB shares will likely require pipeline success, which is not expected until 2014 data readouts from anti-LINGO Phase II (optic neuritis … |
Heart-break causes more suicides than unemployment: NCRB report – Daily News & Analysis
|
Heart-break causes more suicides than unemployment: NCRB report
Daily News & Analysis More people in India end their lives due to heart-break than unemployment or bankruptcy/sudden change in the economic status according to the National Crime Records Bureau (NCRB) ‘Accidental Deaths and Suicides in India 2012′ report. Not only that … |